Association between the systemic immune-inflammation index and the outcome of liver fibrosis in patients with chronic hepatitis C

Association between the systemic immune-inflammation index and the outcome of liver fibrosis in patients with chronic hepatitis C

BackgroundRisk factors that influence the outcome of patients with chronic hepatitis C (CHC) are not fully understood. The systemic immune-inflammatory index (SII) is an independent prognostic factor for multiple diseases. However, the impact of the SII on the outcome of liver fibrosis is unclear.Me...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yuanji Ma, Jiayi Wang, Lingyao Du, Hong Tang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-11-01
Series:	Frontiers in Medicine
Subjects:	chronic hepatitis C liver fibrosis risk factor systemic immune-inflammation index outcome
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2024.1486503/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Serum Elabela Level as a Reliable Biomarker for Predicting of Liver Fibrosis in Iraqi Patients with Chronic Hepatitis C
by: Eham Amer Ali, et al.
Published: (2024-07-01)

Cellular and immune landscape of chronic liver diseases: insights from immunophenotyping
by: Shaghayegh Soleimani, et al.
Published: (2025-01-01)

Pharmacotherapy of Liver Fibrosis and Hepatitis: Recent Advances
by: Liangtao Zhao, et al.
Published: (2024-12-01)

Non-Invasive Test for Assessment of Liver Fibrosis in Chronic Hepatitis B
by: Ye Ji Jun, et al.
Published: (2024-11-01)

Predictors of liver fibrosis changes assessed by paired liver biopsies in chronic hepatitis C patients treated with direct-acting antivirals
by: Ming-Han Hsieh, et al.
Published: (2024-12-01)

Long-Term Monitoring of Liver Fibrosis and Steatosis in Patients with Chronic Hepatitis C after Achieving a Sustained Virologic Response to Antiviral Therapy
by: K. R. Dudina, et al.
Published: (2023-02-01)

MONOCYTE ADHESION MOLECULES EXPRESSION IN PATIENTS WITH CHRONIC HEPATITIS C AND LIVER CIRRHOSIS
by: Nora E.I. El-Bassiouni, et al.
Published: (2013-09-01)

Effect of fatty liver disease on liver function and fibrosis in patients with chronic hepatitis B: a cross-sectional study
by: Xiaohui Fang, et al.
Published: (2024-11-01)

Differential effects of systemic immune inflammation indices on hepatic steatosis and hepatic fibrosis: evidence from NHANES 1999–2018
by: Shuyin Duan, et al.
Published: (2024-12-01)

Therapeutic effects of reduced glutathione on liver function, fibrosis, and HBV DNA clearance in chronic hepatitis B patients
by: Qiyao Wei, et al.
Published: (2025-02-01)

Noninvasive diagnosis of significant liver fibrosis in patients with chronic hepatitis B using nomogram and machine learning models
by: Chuan Jiang, et al.
Published: (2025-01-01)

Chronic hepatitis C course at elderly and therapeutic approach
by: M. V. Mayevskaya, et al.
Published: (2011-02-01)

Antiviral therapy and regression of liver fibrosis at chronic hepatitis B
by: D. T. Abdurakhmanov
Published: (2010-02-01)

Changes in DNA methylation profile in liver tissue during progression of HCV-induced fibrosis to hepatocellular carcinoma
by: I. A. Goncharova, et al.
Published: (2023-03-01)

Noninvasive diagnosis model for predicting significant liver inflammation in patients with chronic hepatitis B in the immune-tolerant phase
by: Shanshan Chen, et al.
Published: (2025-01-01)

Non-linear association between liver fibrosis scores and viral load in patients with chronic hepatitis B
by: Gi-Ae Kim, et al.
Published: (2024-10-01)

Improvement of liver fibrosis verification using new minimally invasive markers in patients with chronic diffuse liver diseases
by: Yu.M. Stepanov, et al.
Published: (2022-12-01)

Impact of hepatic steatosis on liver stiffness measurement by vibration-controlled transient elastography and its diagnostic performance for identifying liver fibrosis in patients with chronic hepatitis B
by: Zhiyuan Chen, et al.
Published: (2024-11-01)

Liver histology pattern of young patients with inactive chronic hepatitis b virus infection from a hospital in South West Nigeria
by: Modupeola Maria Oje, et al.
Published: (2024-11-01)

Comparison of different noninvasive scores for assessing hepatic fibrosis in a cohort of chronic hepatitis C patients
by: Mohamed El-Kassas, et al.
Published: (2024-11-01)

Evaluation of liver fibrosis in HCV-infected patients using two-dimensional shear-wave elastography (2D-SWE) before and after antiviral treatment
by: Inglot Marcin, et al.
Published: (2024-12-01)

Association between intrahepatic cccDNA and the severity of liver inflammation in chronic hepatitis B virus infection patients
by: Suxian Zhao, et al.
Published: (2025-01-01)

The processes of inflammation and fibrosis in patients with chronic obstructive pulmonary disease
by: T.A. Pertseva, et al.
Published: (2020-12-01)

Polymorphism of renin — angiotensin system genes in progression of liver fibrosis in patients with chronic hepatitis C
by: O. V. Taratina, et al.
Published: (2014-08-01)

KASL clinical practice guidelines for noninvasive tests to assess liver fibrosis in chronic liver disease
by: Mi Na Kim, et al.
Published: (2024-09-01)

Progress and prospects of elastography techniques in the evaluation of fibrosis in chronic liver disease
by: Yang Wang, et al.
Published: (2024-04-01)

Long-Term Results of the Etiotropic Therapy of Subcompensed Liver Cirrhosis in the Outcome of Chronic Hepatitis C
by: P. O. Bogomolov, et al.
Published: (2020-01-01)

Value of autotaxin as a serum marker for liver fibrosis in chronic HCV infected patients receiving direct-acting antiviral therapy
by: Ahmed Moustafa, et al.
Published: (2024-08-01)

The validity of serum autotaxin as a predictor of hepatic fibrosis in patients with nonalcoholic fatty liver disease
by: Muhammad Abdel-Gawad, et al.
Published: (2023-10-01)

Metabolic Dysfunction-Associated Steatotic Liver Disease in Chronic Hepatitis C Virus Infection: From Basics to Clinical and Nutritional Management
by: Karina Gonzalez-Aldaco, et al.
Published: (2024-11-01)

Exploring Risk Factors for Primary Liver Cancer in Patients with Chronic Hepatitis C Based on Machine Learning Prediction Models
by: Rong YANG, et al.
Published: (2024-12-01)

Association between NAFLD and liver fibrosis with nutritional risk index based on the NHANES 2017–2018
by: Jieming Jian, et al.
Published: (2025-01-01)

Advanced Imaging Techniques for Assessing Fat, Iron, and Fibrosis in Chronic Liver Disease
by: Sabarish Narayanasamy, et al.
Published: (2025-01-01)

ETIOLOGICAL CHARACTERISTICS OF CHRONIC VIRAL HEPATITIS IN THE KHOREZM REGION OF UZBEKISTAN
by: Shavkat R. Yusupov, et al.
Published: (2023-06-01)

Assessment of hepatic fibrosis in patients with rheumatoid arthritis on long-term methotrexate therapy using transient elastography
by: Abhishek Kumar, et al.
Published: (2018-01-01)

Vibration-controlled transient elastography for significant fibrosis in treatment-naïve chronic hepatitis B patients: A systematic review and meta-analysis
by: Mi Na Kim, et al.
Published: (2024-09-01)

Plasma microRNA-15a/16-1 serves as a non-invasive indicator of liver fibrosis severity in individuals with chronic hepatitis B
by: Huan Wei, et al.
Published: (2024-12-01)

The role of the interleukin family in liver fibrosis
by: Zixin Zhang, et al.
Published: (2025-02-01)

THE COURSE OF HEPATITIS C INFECTION AND RESPONSE TO ANTI-VIRAL THERAPY IN PATIENTS WITH THALASSEMIA MAJOR AND HEPATITIS C INFECTION: A LONGITUDINAL, PROSPECTIVE STUDY.
by: Sanaa Kamal, et al.
Published: (2019-10-01)

Diastolic dysfunction of myocardium and change of <i>Q–T</i> interval at chronic hepatitis C
by: A. A. Konysheva, et al.
Published: (2012-11-01)